To verify this hypothesis, we conducted a screening study for NPC1 and NPC2 mutations in 50 Calabrian patients affected by dementia with atypical clinical presentations or dementia plus, in which progressive and invalidating cognitive impairment was the main clinical feature associated with other neuropsychiatric and systemic symptoms [14]. The gene discussed is NPC2; the disease is dementia.